LOU REESE: The largest gains in human longevity ever are debatably attributed to vaccine technology.
The antibiotic revolution was very important, but vaccine technology is currently over 6.2 billion people in the world have been vaccinated right now. These are the most widely distributed medications and solutions that have ever been brought to mankind. And the consequence was that we really dramatically improved our quality of life and our longevity. We gave people better, healthier, longer lives.
LARRY BRILLIANT: Vaccines are the best thing science has ever given us. It saved hundreds of millions of children’s lives. It eradicated smallpox. It has reduced the population explosion. I know that’s pretty paradoxical but as long as there are vaccines children will not die as they did when I was in India. There were places that 50 percent of kids died before the age of five. When that happens parents have many
BISMARCK, N.D. (KFYR) – Eliminating a novel virus might require a novel approach. Vaccine makers Moderna and Pfizer are using messenger RNA, or mRNA, to produce their vaccines.
This new technology has never before received regulatory approval.
If the mRNA vaccines make it to the general public, doctors say they will look indistinguishable from traditional vaccines.
However, they work in a different way. Instead of injecting a dead or weakened version of the virus into the patient’s body, doctors will be injecting the genetic information to produce the antigen, or antibodies, to fight the disease.
Companies are developing mRNA vaccines to combat coronavirus, and people seem to be on the fence about the new method.
“I honestly don’t know. I guess I would probably wait for a while and see how things go before I would get the vaccine,” said Dickinson Resident Darcy
Technavio has been monitoring the dengue vaccine market and it is poised to grow by $ 630.65 million during 2020-2024, progressing at a CAGR of over 26% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200925005218/en/
Technavio has announced its latest market research report titled Global Dengue Vaccine Market 2020-2024 (Graphic: Business Wire)
Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization
With Zachary Brennan, David Lim and Lauraine Genota
— “We need science to be the place of trust.” What happened with the vaccine guidance.
— Trump’s importation plan is here with savings TBD.
— Science academies sound the alarm on political interference with Covid-19 vaccines.
It’s Friday, welcome back to Prescription Pulse. Happy birthday, Hatch-Waxman Act! H/t Zachary Brennan for the reminder. As always, send pharma tips and news to [email protected] or @owermohle. Loop in David Lim ([email protected] or @davidalim) and Zachary Brennan ([email protected] or @ZacharyBrennan)!
WHAT HAPPENED WITH THE VACCINE GUIDANCE? FDA Commissioner Stephen Hahn spent weeks preparing a proposal to set morestringent standards for emergency authorization
Video above: COVID vaccine tested, experts say no corners cutDr. Anthony Fauci said Thursday that even an effective COVID-19 vaccine won’t replace the need for other public health measures, such as wearing a mask, social distancing and washing hands.Fauci, the director of the National Institute of Allergy and Infectious Diseases, said the vaccine will not be 100% effective and taken by 100% of the population — which means there still will be room for COVID-19 to spread.”it is not going to eliminate the need to be prudent and careful with our public health measures,” he said in a Facebook Live conversation with New Jersey Gov. Phil Murphy.Fauci said he’s being “practical” when he says, “I think if we can get 75 to 80% of the population vaccinated, I think that would be a really good accomplishment.”Fauci’s comments were made as nearly half of U.S. states now report a rise in … Read More
Americans that get the first Covid-19 vaccines will be closely monitored by the U.S. Centers for Disease Control and Prevention through daily text messages and emails, according to a federal advisory group.
Essential workers who are expected to be the first recipients will get daily text messages on their smartphones asking about side effects in the first week after they get the shot, and then they’ll be contacted weekly for six weeks, said Tom Shimabukuro, a CDC immunization expert, at a meeting of the CDC’s Advisory Committee on Immunization Practices. Those workers could total about 20 million people, he said.
The advisers also heard that the CDC and the Defense Department have set up technical assistance teams to help state and local jurisdictions develop and implement distribution plans. The plans are due for review and approval by October 16, said Janell Routh, a CDC
Daily smartphone tracking planned for first recipients of COVID-19 vaccine
Stars and Stripes is making stories on the coronavirus pandemic available free of charge. See other free reports here. Sign up for our daily coronavirus newsletter here. Please support our journalism with a subscription.
WASHINGTON (Tribune News Service) — Americans that get the first COVID-19 vaccines will be closely monitored by the U.S. Centers for Disease Control and Prevention through daily text messages and emails, according to a federal advisory group.
Essential workers who are expected to be the first recipients will get daily text messages on their smartphones asking about side effects in the first week after they get the shot, and then they’ll be contacted weekly for six weeks, said Tom Shimabukuro, a CDC immunization expert, at a meeting of the CDC’s Advisory Committee on Immunization Practices. Those workers could total about